Compare PTCT & BC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | BC |
|---|---|---|
| Founded | 1998 | 1845 |
| Country | United States | United States |
| Employees | N/A | 14000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.4B |
| IPO Year | 2006 | N/A |
| Metric | PTCT | BC |
|---|---|---|
| Price | $75.18 | $82.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | $80.65 | ★ $83.55 |
| AVG Volume (30 Days) | ★ 1.0M | 541.1K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.22% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $9.81 |
| Revenue Next Year | $17.70 | $5.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $43.18 | $54.49 |
| 52 Week High | $87.50 | $90.25 |
| Indicator | PTCT | BC |
|---|---|---|
| Relative Strength Index (RSI) | 60.42 | 54.67 |
| Support Level | $73.41 | $73.66 |
| Resistance Level | $79.67 | $84.76 |
| Average True Range (ATR) | 2.59 | 2.57 |
| MACD | 0.43 | -0.10 |
| Stochastic Oscillator | 90.99 | 57.10 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns more than 450 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.